Hydrogen Coral Calcium Safely Lowers Triglycerides in Metabolic Syndrome
Evaluation of the safety and potential lipid-lowering effects of oral hydrogen-rich coral calcium (HRCC) capsules in patients with metabolic syndrome: a prospective case series study
Research hubs: Metabolic Syndrome · Type 2 Diabetes · Cardiovascular System · Endocrine System

- Evidence type
- Uncontrolled trial (single-arm or pilot) · Human study
- Authors
- Szu-Han Chiu, Frank L. Douglas, Jia-Ru Chung, Kuang-Yih Wang, Chao-Fang Chu, Hsia-Yun Chou, Wei-Chih Huang, Tian-Yu Wang, Wen-Wen Chen, Min-Chung Shen, Feng-Cheng Liu, Po-Jen Hsiao
- Journal
- Frontiers in Nutrition
- Year
- 2023
- PMID
- 37521410
- Study Type
- Human
- Participants
- 16
- Delivery
- Gas (Sustained Release)
- Dose
- 3 different doses (low, medium, and high) of HRCC capsules for 4 weeks
- Duration
- 4 weeks
- Funding
- HoHo Biotech (ho202102040)
- Conflicts of interest
- FD, J-RC, K-YW, C-FC, H-YC, and W-CH were employed by HoHo Biotech Co., Ltd. T-YW was employed by HoGo Force Co., Ltd. The funder had involvement in experiment design, data collection, and decision to publish.
- Outcome
- Positive
- Peer Reviewed
- Yes
- Cited by
- 5 (OpenAlex, as of November 2026)
- Country
- Taiwan
TL;DR
A study found that taking hydrogen-rich coral calcium (HRCC) capsules can safely lower triglyceride levels in people with metabolic syndrome.
Key Finding
Hydrogen-rich coral calcium capsules were safe and well-tolerated in patients with metabolic syndrome, with triglyceride levels dropping significantly after 4 weeks of treatment.
Summary
This small study tested hydrogen-rich coral calcium capsules in 16 patients with metabolic syndrome (a cluster of conditions including high blood pressure, high blood sugar, and high cholesterol) over 4 weeks. The capsules were safe with no serious side effects, and triglycerides (a type of fat in the blood) decreased significantly, dropping from an average of 193 to 152 units. However, other cholesterol measures and quality of life did not show significant changes in this short study.
Practical Takeaway
This early human study suggests hydrogen-rich coral calcium may help lower triglycerides in people with metabolic syndrome, but the study was very small (16 people) and lasted only 4 weeks. Much longer and larger studies are needed before we can know whether this product would be genuinely useful for managing metabolic syndrome or cardiovascular health.
Abstract (excerpt)
BackgroundMetabolic syndrome is characterized by a cluster-like occurrence of conditions such as hypertension, hyperglycaemia, elevated low-density lipoprotein (LDL) cholesterol or triglycerides (TG) and high visceral fat. Metabolic syndrome is linked to the build-up of plaque within the artery…